Study period | 2010–2011 | 2015–2016 | |||
---|---|---|---|---|---|
National guideline launched | 2009 | 2015 | |||
Total study population (N) | 679 | 628 | |||
By genders (N) | Male: 320 | Female:359 | Male: 312 | Female:316 | |
≤60 years | 141 | 133 | 119 | 92 | |
> 60 years | 179 | 226 | 193 | 224 | |
Average age [years±SD] | 62.3 ± 11.5 | 62.7 ± 10.8 | |||
Years under treatment, means [±SD] | 8.7 ± 6.4 | 10.2 ± 7.4 | |||
BMI > 25 kg/m2 [%] | 81.8 | 83.9 | |||
BMI > 30 kg/m2[%] | 40.6 | 44.4 | |||
waist circumference (men: > 102 cm, women: > 88 cm) [%] | 64.3 | 62.0 | |||
Smoking [%] | 21.6 | 21.0 | |||
STUDY SUBGROUPS | STUDY SUBGROUPS | ||||
A | B | C | D | E | |
Subgroups by risk | ASY | HR-CVD | VHR | HR | VHR |
BLOOD PRESSURE | |||||
Target value [mmHg] | < 140/90 | < 130/80 | < 130/80 | < 140/90 DM: < 140/85 Nephropathy+proteinuria: < 130/80 | |
Proportion of patients on target [%] | 75.8* | 37.1 | 30.1 | 60.0* | 42.7 |
LDL-CHOLESTEROL | |||||
Target value [mmol/l] | < 3.0 | < 2.5 | < 1.8 | < 2.5 | < 1.8 |
Proportion of patients on target [%] | 47.5 | 33.3 | 10.7* | 39.3 | 15.8* |
TRIGLICERIDE | |||||
Target value [mmol/l] | < 1.7 | < 1.7 | |||
Proportion of patients on target [%] | 38.5 | 55.2 | 42.1 | 47.8 | 45.0 |
HDL-CHOLESTEROL | |||||
Target value [mmol/l] | > 1.0 (male) > 1.3 (female) | > 1.0 (male) > 1.3 (female) | |||
Proportion of patients on target [%] | 71.6 | 65.6 | 64.1 | 66.7 | 68.0 |
DIABETES | |||||
Target value [HbA1c [%] | < 7.0 | < 7.0 | |||
Proportion of patients on target [%] | 42.0 | 40.0 |